RecruitingPhase 3NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)Sponsor: Bristol-Myers SquibbFoxborough, MA · Newton, MA · South Dartmouth, MA · +38 more sites
RecruitingPhase 2NCT07589595A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)Sponsor: Eli Lilly and CompanyCharlestown, MA · Foxborough, MA · +39 more sites
RecruitingPhase 2NCT06808984Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseaseSponsor: CelgeneFoxborough, MA · South Dartmouth, MA · +58 more sites